Skip to main content
Log in

Pulmonary function in thyroid carcinoma metastatic to the lung

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Pulmonary testing was carried out in 12 of 35 consecutive cases of differentiated thyroid carcinoma metastatic to the lung, which were identified in a retrospective analysis covering the 22-yr period from 1962–1984. In 7 of the 12 patients, pulmonary function tests showed abnormalities. Impaired pulmonary function was associated with a poor prognosis. Four of the twelve patients died; each had impaired pulmonary function and their ages (12–65 yr) were similar to those still living (13–65 yr). Specific types of functional abnormalities were not associated with pulmonary metastases, and underlying pulmonary disease contributed to the findings in some patients. Four patterns were defined on chest radiographs: macronodular, micronodular, miliary, and normal, but these patterns did not correlate with outcome. Scintiscan patterns varied from normal to diffuse concentration of 131I. Generally, following therapy with radioiodine, fewer abnormalities on chest x-ray and less uptake of 131I in the lungs was noted. However, therapy with radioiodine did not improve pulmonary function. Pulmonary function testing appears to be a better predictor of outcome in patients with thyroid carcinoma metastatic to lung than chest x-ray appearance or scintigraphic scanning.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Samaan N., Schultz P., Haynie T., Ordonez N. Pulmonary metastasis of differentiated thyroid carcinoma: Treatment results in 101 patients. J. Clin. Endocrinol. Metab. 65: 376, 1985.

    Article  Google Scholar 

  2. Woolner L Thyroid carcinoma: pathologic classification with data on prognosis. Semin. Nucl. Med. 1: 481, 1971.

    Article  PubMed  CAS  Google Scholar 

  3. Beierwaltes W.H., Nishiyama N., Thompson N., Copp J., Kubo A. Survival time and “cure” in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy. J. Nucl. Med. 23: 561, 1982.

    PubMed  CAS  Google Scholar 

  4. Cady B., Sedgwich C., Meissner W., Wool M., Salzman F., Werber J. Risk factor analysis in differentiated thyroid cancer. Cancer 43: 810, 1979.

    Article  PubMed  CAS  Google Scholar 

  5. Leeper R. The effect of 131I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma. J. Clin. Endocrinol. Metab. 36: 1143, 1972.

    Article  Google Scholar 

  6. Samaan N., Maheshwari Y., Nader S., Hill C., Schultz P., Haynie T., Hickey R., Clark R., Goepfert H., Ibanez M., Litton C. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J. Clin. Endocrinol. Metab. 56: 1131, 1983.

    Article  PubMed  CAS  Google Scholar 

  7. Massin J.-P., Savoie J.-C., Gamier H., Guiraudon G., Leger F., Bacourt F. Pulmonary metastases in differentiated thyroid carcinoma. Cancer 53: 982, 1984.

    Article  PubMed  CAS  Google Scholar 

  8. Rall J., Alpers J., Lewallen C., Sonenberg M., Berman M., Rawson R. Radiation pneumonitis and fibrosis: a complication of radioiodine treatment of pulmonary metastases from cancer of the thyroid. J. Clin. Endocrinol. Metab. 17: 1263, 1957.

    Article  PubMed  CAS  Google Scholar 

  9. Haynie T.P., Nofal M.M., Beierwaltes W.H. Treatment of thyroid carcinoma with 131I: Results at 14 years. JAMA 183: 303, 1963.

    Article  PubMed  CAS  Google Scholar 

  10. Nemec J., Zamrazil V., Pohunkova D., Rohling S., Holik F., Zeman V. Rontgenologische charakteristik von lungen metastasen des schildrusenkarzinoms mit bezug auf sein biologisches verhalten. Fortschr. Geb. Rontgenstr. Nuclearmed. 131: 261, 1979.

    Article  CAS  Google Scholar 

  11. Morris J.F., Koski A., Johnson A.C. Spirometric standards for healthy non-smoking subjects. Am. Rev. Respir. Dis. 103: 57, 1971.

    PubMed  CAS  Google Scholar 

  12. Harness J., Thompson N., Sisson J. Differentiated thyroid carcinomas. Arch. Surg. 108: 410, 1974.

    Article  PubMed  CAS  Google Scholar 

  13. Beierwaltes W.H. Indications and contraindications for treatment of thyroid cancer with radioactive iodine. Ann. Intern. Med. 27: 23, 1952.

    Google Scholar 

  14. Woolman S. Analysis or radioiodine therapy in metastatic tumors of the thyroid gland in man. J. Natl. Cancer Inst. 13: 815, 1953.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aldrich, L.B., Sisson, J.C. & Grum, C.M. Pulmonary function in thyroid carcinoma metastatic to the lung. J Endocrinol Invest 10, 111–116 (1987). https://doi.org/10.1007/BF03347168

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347168

Key-words

Navigation